Based on the information available, there is no definitive evidence to suggest that vaccines have a significant impact on the effectiveness of Cosentyx (secukinumab) [1]. Cosentyx is a biologic medication used to treat various conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [2]. It works by targeting a specific protein in the body that contributes to inflammation [2].

Vaccines, on the other hand, stimulate the body's immune system to build protection against specific infectious diseases [3]. The potential interaction between vaccines and biologic medications like Cosentyx is an area of ongoing research [1]. Some studies suggest that certain vaccines may have reduced effectiveness in individuals taking biologic drugs, but the impact can vary depending on the specific vaccine and medication [1].

It is essential to consult with a healthcare provider to discuss any concerns about vaccine effectiveness while taking Cosentyx. They can provide personalized guidance based on the individual's health status and treatment plan [1].

Sources:

[1] DrugPatentWatch.com. (2022). Secukinumab (Cosentyx). Retrieved from https://www.drugpatentwatch.com/drugs/secukinumab

[2] Mayo Clinic. (2021). Cosentyx (secukinumab). Retrieved from https://www.mayoclinic.org/drugs-supplements/cosentyx-secukinumab-subcutaneous-route/description/drg-20115521

[3] Centers for Disease Control and Prevention. (2022). Vaccines & Immunizations. Retrieved from https://www.cdc.gov/vaccines/index.html